BusinessNew Data Demonstrate the Biodesix VeriStrat® Liquid Biopsy Test Reliably Informs Lung Cancer Treatment DecisionsBy Nasdaq OMXApr 30, 2018, 1:20 PM UTC
BusinessThe Global Metabolomics Market (Forecast: 2017–2022)—Top Down AnalyticsBy Nasdaq OMXApr 25, 2018, 12:01 PM UTC
BusinessKey Strategies for Implementing Proteomics-Based Tests Across Disease States Highlighted in Current Opinion in BiotechnologyBy Nasdaq OMXFeb 12, 2018, 1:01 PM UTC
BusinessResearch Antibodies and Reagents Market Worth 13,276.5 Million USD By 2023By Nasdaq OMXJan 29, 2018, 2:39 PM UTC
BusinessBiodesix Presents Data From Three Studies at AACR Annual MeetingBy Nasdaq OMXApr 5, 2017, 12:01 PM UTC
